Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Life and Health Insurance Industry Analysis

UpdatedApr 05, 2026
DataAggregated Company Financials
Companies22
  • 7D3.9%
  • 3M-9.2%
  • 1Y8.3%
  • YTDn/a

Over the last 7 days, the Life and Health Insurance industry has risen 3.9%, driven by gains in Aflac and MetLife of 3.8% and 4.5%, respectively. This means that the industry has gained 8.3% over the past year. Looking forward, earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026US$232.1bUS$260.6bUS$16.6b14.6x13.9x0.9x
Tue, 03 Mar 2026US$235.4bUS$260.6bUS$16.6b14.9x14.1x0.9x
Thu, 29 Jan 2026US$239.4bUS$255.6bUS$19.7b13x12.1x0.9x
Sat, 27 Dec 2025US$253.3bUS$255.6bUS$19.7b13.1x12.8x1x
Mon, 24 Nov 2025US$241.5bUS$255.6bUS$19.7b12.3x12.2x0.9x
Wed, 22 Oct 2025US$242.8bUS$254.5bUS$15.7b13.1x15.5x1x
Fri, 19 Sep 2025US$249.9bUS$254.5bUS$15.7b13.6x16x1x
Sun, 17 Aug 2025US$243.7bUS$254.5bUS$15.7b13.5x15.6x1x
Tue, 15 Jul 2025US$241.4bUS$257.6bUS$18.1b12.1x13.3x0.9x
Thu, 12 Jun 2025US$224.8bUS$243.3bUS$17.6b12.2x12.8x0.9x
Sat, 10 May 2025US$227.4bUS$243.3bUS$17.6b12.2x12.9x0.9x
Mon, 07 Apr 2025US$213.0bUS$250.3bUS$22.4b10.1x9.5x0.9x
Wed, 05 Mar 2025US$240.6bUS$250.4bUS$22.5b10.3x10.7x1x
Fri, 31 Jan 2025US$244.4bUS$242.9bUS$14.3b14.6x17.1x1x
Sun, 29 Dec 2024US$230.8bUS$242.9bUS$14.3b13.6x16.2x1x
Tue, 26 Nov 2024US$248.3bUS$242.9bUS$14.3b14.9x17.4x1x
Thu, 24 Oct 2024US$244.5bUS$229.8bUS$16.6b13.7x14.7x1.1x
Sat, 21 Sep 2024US$241.9bUS$229.8bUS$16.6b13.2x14.6x1.1x
Mon, 19 Aug 2024US$227.1bUS$229.8bUS$16.6b12.5x13.7x1x
Wed, 17 Jul 2024US$226.8bUS$222.7bUS$14.7b9.9x15.4x1x
Fri, 14 Jun 2024US$212.8bUS$225.4bUS$14.8b10.4x14.3x0.9x
Sun, 12 May 2024US$215.6bUS$225.4bUS$14.8b12.4x14.6x1x
Tue, 09 Apr 2024US$222.8bUS$216.9bUS$10.3b16.9x21.7x1x
Thu, 07 Mar 2024US$214.1bUS$216.9bUS$10.2b16x21.1x1x
Sat, 03 Feb 2024US$252.4bUS$215.5bUS$4.9b14.5x51.5x1.2x
Mon, 01 Jan 2024US$255.8bUS$216.4bUS$1.6b13.4x157x1.2x
Wed, 29 Nov 2023US$247.7bUS$216.4bUS$1.6b12.8x152.1x1.1x
Fri, 27 Oct 2023US$236.6bUS$239.0bUS$1.1b12x217.3x1x
Sun, 24 Sep 2023US$244.1bUS$238.9bUS$1.0b12.9x238.8x1x
Tue, 22 Aug 2023US$241.4bUS$238.9bUS$1.0b13.2x236.1x1x
Thu, 20 Jul 2023US$242.4bUS$240.0bUS$5.5b12.9x44.1x1x
Sat, 17 Jun 2023US$228.8bUS$240.0bUS$5.5b12.4x41.6x1x
Mon, 15 May 2023US$214.5bUS$239.9bUS$5.6b11.3x38.3x0.9x
Wed, 12 Apr 2023US$229.0bUS$236.5bUS$11.3b6.9x20.2x1x
Price to Earnings Ratio

20.2x


Total Market Cap: US$229.0bTotal Earnings: US$11.3bTotal Revenue: US$236.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life and Health Insurance Industry Price to Earnings3Y Average 43.4x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.9x which is lower than its 3-year average PE of 43.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 3.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?

US Market3.46%
Financials3.50%
Insurance2.75%
Life and Health Insurance3.88%
Insurance Brokers3.67%
Reinsurance3.22%
Property and Casualty Insurance2.02%
General Insurance1.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AFL AflacUS$110.483.8%
+US$2.1b		8.3%PE15.6x
MET MetLifeUS$70.724.5%
+US$2.0b		2.4%PE14.5x
PRU Prudential FinancialUS$97.584.6%
+US$1.5b		1.1%PE9.6x
PFG Principal Financial GroupUS$90.103.6%
+US$670.0m		23.5%PE16.5x
GL Globe LifeUS$142.605.5%
+US$587.6m		21.7%PE9.6x

Latest News

BHF
US$59.78
Brighthouse Financial
7D
-0.3%
1Y
21.9%

Brighthouse Financial: A Deal-Driven Opportunity, Not A Long-Term Compounder

Apr 05
PFG
US$90.10
Principal Financial Group
7D
3.6%
1Y
23.5%

PFG: Capital Strength And Buybacks Will Support Higher Sector Pricing

Analysts have made modest upward adjustments to Principal Financial Group's price targets, with several moving into the $85 to $95 range. They cite updated views on revenue growth, profitability, and sector valuation for life and annuity insurers.
PRI
US$253.85
Primerica
7D
3.1%
1Y
2.2%
AFL
US$110.48
Aflac
7D
3.8%
1Y
8.3%

AFL: Future Returns Will Reflect Capital Strength And Earnings Execution Risks

Narrative Update The analyst price target framework for Aflac now centers around $113. This reflects updated Street work, with some firms raising targets toward $118 and others trimming into the $101 to $120 range as analysts refresh earnings estimates and extend their valuation horizons.
MET
US$70.72
MetLife
7D
4.5%
1Y
2.4%

MET: Share Repurchases And Index Exit Will Shape Future Upside Potential

Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.
GL
US$142.60
Globe Life
7D
5.5%
1Y
21.7%

GL: Higher P/E Assumptions And Capital Returns Will Shape Balanced Future Outcomes

Analysts have raised their price target on Globe Life to $150, up from $145. This change reflects updated assumptions for revenue growth, profit margins and future P/E multiples in their models.
BNT
US$41.98
Brookfield Wealth Solutions
7D
3.4%
1Y
36.0%
FG
US$26.05
F&G Annuities & Life
7D
7.6%
1Y
-23.7%
PRU
US$97.58
Prudential Financial
7D
4.6%
1Y
1.1%

PRU: Capital Strength And Cash Flow Will Support Resilient Income And Buybacks

Prudential Financial's analyst price target edges lower in this update, with fair value revised from about $111.79 to $109.80 as analysts factor in slightly higher discount rates, softer revenue growth assumptions, modestly higher profit margins, and a lower future P/E multiple following recent sector wide reassessments of cash flow and private credit risk. Analyst Commentary Recent Street research on Prudential Financial points to a more cautious tone, with several firms trimming price targets and reassessing risk around cash flow, private credit exposure, and business mix.